PMID- 38158418 OWN - NLM STAT- MEDLINE DCOM- 20240214 LR - 20240214 IS - 1434-4726 (Electronic) IS - 0937-4477 (Linking) VI - 281 IP - 3 DP - 2024 Mar TI - Chemoradiotherapy vs radiotherapy for non-surgical locally advanced laryngeal squamous cell carcinoma patients: a propensity score-matched study and practical nomogram construction. PG - 1449-1456 LID - 10.1007/s00405-023-08360-8 [doi] AB - OBJECTIVE: To compare the cancer-specific survival (CSS) among patients with locally advanced laryngeal squamous cell carcinoma (LSCC) receiving chemoradiotherapy (CRT) and radiotherapy (RT) treatment, as well as to establish a prognostic nomogram for survival prediction in patients receiving CRT. METHOD: Using data from the Surveillance, Epidemiology, and End Results (SEER) database, patients with laryngeal cancer were identified between 2010 and 2015, with follow-up up to 2018. Propensity score matching (PSM) was performed to minimize disproportionate distributions of the potential confounding. Cox regression models were used to evaluate the CSS of two treatment groups. A prognostic nomogram for patients receiving CRT was then developed and evaluated. RESULTS: Totally 1085 non-surgical patients with locally advanced LSCC were included in this study (median [IQR] age, 62 [55-69] years; 829 [76.41%] males), of which 913 receiving CRT and 172 receiving RT. After PSM, significantly improved CSS was observed in locally advanced LSCC patients receiving CRT when compared to RT (HR: 0.62 [95% CI 0.42-0.92]; P = 0.014). Then, in the group of 639 locally advanced LSCC patients receiving CRT, a prognostic nomogram based on age, tumor size, N category, and marital status were developed and validated, of which the predictive performance was superior to that of TNM staging system (7th edition). CONCLUSION: CSS shows a statistically significant improvement in locally advanced LSCC patients who receipt of CRT when compared with RT. Furthermore, a prognostic nomogram for locally advanced LSCC patients receiving CRT was established, which shows a good calibration and identification accuracy. CI - (c) 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. FAU - Zhang, Yuan AU - Zhang Y AUID- ORCID: 0009-0007-0025-179X AD - Department of Otolaryngology-Head and Neck Surgery, West China Hospital of Sichuan University, Chengdu, China. AD - Department of Audiology, Guizhou Provincial People's Hospital, Guiyang, China. FAU - Wang, Zhipeng AU - Wang Z AD - Department of Audiology, Guizhou Provincial People's Hospital, Guiyang, China. FAU - Zheng, Yun AU - Zheng Y AUID- ORCID: 0000-0002-0399-6064 AD - Department of Otolaryngology-Head and Neck Surgery, West China Hospital of Sichuan University, Chengdu, China. 1141679315@qq.com. LA - eng PT - Journal Article DEP - 20231229 PL - Germany TA - Eur Arch Otorhinolaryngol JT - European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery JID - 9002937 SB - IM MH - Male MH - Humans MH - Middle Aged MH - Female MH - Squamous Cell Carcinoma of Head and Neck MH - *Nomograms MH - Propensity Score MH - Prognosis MH - Chemoradiotherapy MH - *Head and Neck Neoplasms OTO - NOTNLM OT - Cancer-specific survival OT - Laryngeal squamous cell carcinoma OT - Nomogram OT - Propensity score matching EDAT- 2024/01/02 11:43 MHDA- 2024/02/10 22:54 CRDT- 2023/12/29 23:18 PHST- 2023/10/10 00:00 [received] PHST- 2023/11/14 00:00 [accepted] PHST- 2024/02/10 22:54 [medline] PHST- 2024/01/02 11:43 [pubmed] PHST- 2023/12/29 23:18 [entrez] AID - 10.1007/s00405-023-08360-8 [pii] AID - 10.1007/s00405-023-08360-8 [doi] PST - ppublish SO - Eur Arch Otorhinolaryngol. 2024 Mar;281(3):1449-1456. doi: 10.1007/s00405-023-08360-8. Epub 2023 Dec 29.